This site has been redesigned, and is now in Weblog format. Below are all articles from the old Journalclub site.

items posted between October, 2003 and October, 2004

Drug-delivering coronary artery stents: bare metal threatened by extinction?
Sigwart U
Lancet 2003 Oct 4;362(9390):1088.

The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL
N Engl J Med 2003 Oct 2;349(14):1333-40.

A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.
Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M
N Engl J Med 2003 Jan 2;348(1):5-14.

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein.
Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, Connelly PW
JAMA 2003 Jul 23;290(4):502-10.

Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis.
Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ
N Engl J Med 2003 Sep 25;349(13):1227-1235.

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD
JAMA 2003 Sep 17;290(11):1459-66.

articles from the old Journal Club website (1995-2000)

This is the list of all article summaries and other items posted to Journal Club, from 1995-2000. The summaries listed here were up-to-date at the time they were posted.  Many of them no longer are.

74. Vitamin E supplementation and cardiovascular events in high risk patients
New England Journal of Medicine. 342:154-60. January 20, 2000.

73. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
New England Journal of Medicine. 342:145-53. January 20, 2000.
With author's response

72. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
New England Journal of Medicine. 341:709-17. September 2, 1999.

71. Early Lung Cancer Action Project: overall design and findings from baseline screening
Lancet. 354:99-105. July 10, 1999.
 

70. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
New England Journal of Medicine. 340:901-7.

69. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Lancet. 353:345-50. January 30, 1999.

68. Trends in alternative medicine use in the United States, 1990-1997
JAMA. 280:1569-75. November 11, 1998.

67. Three articles on appetite suppressants and valvular heart disease

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs
New England Journal of Medicine. 339:713-8. September 10, 1998.

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
New England Journal of Medicine. 339:719-24. September 10, 1998.

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
New England Journal of Medicine. 339:725-32. September 10, 1998.

66. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
New England Journal of Medicine. 339:357-63. August 6, 1998.

65. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy (VANQWISH)
New England Journal of Medicine. 338:1785-92. June 18, 1998.

64. Oral sildenafil in the treatment of erectile dysfunction
New England Journal of Medicine. 338:1397-404. May 14, 1998.

63. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin
JAMA. 279:1273-7. April 22/29, 1998.

62. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema
Lancet. 351:389-93. February 7, 1998.

61. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
New England Journal of Medicine. 338:557-63. February 26, 1998.

60. Effect of computed tomography of the appendix on treatment of patients and use of hospital resources
New England Journal of Medicine. 338:141-6. January 15, 1998.

59. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
New England Journal of Medicine. 337:1785-91. December 18, 1997.

58. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
New England Journal of Medicine. 337:1648-53. December 4, 1997.

57. Effect of inhaled formoterol and budesonide on exacerbations of asthma
New England Journal of Medicine. 337:1405-11. November 13, 1997.

56. A comparison of sustained-release bupropion and placebo for smoking cessation
New England Journal of Medicine. 337:1195-202. October 23, 1997.

55. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
Lancet. 350:975-9. October 4, 1997.
With authors' response

54. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
Lancet. 350:607-14. August 30, 1997.

53. Valvular heart disease associated with fenfluramine-phentermine
New England Journal of Medicine. 337:581-8. August 28, 1997.

52. Plasma homocysteine levels and mortality in patients with coronary artery disease
New England Journal of Medicine. 337:230-6. July 24, 1997.

51. Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis
New England Journal of Medicine. 337:382-7. August 7, 1997.

50. Prevention of bacterial endocarditis. Recommendations by the American Heart Association.
JAMA. 277:1794-1801. June 11, 1997.

49. Correction of excesssive anticoagulation with oral vitamin K₁
Annals of Internal Medicine. 126:959-62. June 15, 1997.

48. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease
Annals of Internal Medicine. 126:866-73. June 1, 1997.

47. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism
JAMA. 277:1205-13. April 16, 1997.

46. Patient-specific decisions about hormone replacement therapy in postmenopausal women
JAMA. 277:1140-7. April 9, 1997.

45. Bone mass and the risk of breast cancer among postmenopausal women
New England Journal of Medicine. 336:611-7. February 27, 1997.

44. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Lancet. 349:747-52. March 15, 1997.

43. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
New England Journal of Medicine. 335:1001-9. October 3, 1996.

42. The effect of digoxin on mortality and morbidity in patients with heart failure
New England Journal of Medicine. 336:525-33. February 20, 1997.

41. A controlled trial of immunotherapy for asthma in allergic children
New England Journal of Medicine. 336:324-31. January 30, 1997.

40. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against plasmodium falciparum malaria
New England Journal of Medicine. 336:86-91. January 9, 1997.

39. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin
JAMA. 276:1957-63. December 25, 1996.
With authors' response

38. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously
New England Journal of Medicine. 335:1864-9. December 19, 1996.

37. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
New England Journal of Medicine. 335:1713-20. December 5, 1996.

36. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis.
Annals of Internal Medicine. 125:785-93. November 15, 1996.
With authors' response

35. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
New England Journal of Medicine. 335:1107-14. October 10, 1996.

 34. Hormone replacement therapy and the risk of venous thromboembolism. Three studies from the Lancet.
Lancet. 348:977-87. October 7, 1996.

33. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery.
Lancet. 348:841-45. September 28, 1996.

32. A prognostic model for predicting 10-year survival in patients with primary melanoma.
Annnals of Internal Medicine. 125:369-375. September 1, 1996.

31. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS).
JAMA. 276:785-91. September 11, 1996.

30. Appetite-suppressant drugs and the risk of primary pulmonary hypertension.
New England Journal of Medicine. 335:609-16. August 29, 1996.

29. The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
New England Journal of Medicine. 335:242-9. July 25, 1996.
With authors' response

28. Screening for mild thyroid failure at the periodic health examination. A decision and cost-effectiveness analysis.
JAMA. 276:285-92. July 24/31, 1996.
With authors' response

27. Initial experience with partial left ventriculectomy for the treatment of end-stage heart failure.
Arquivos Brasileiros de Cardiologia. 66:189-92. 1996.

26. The long-term course of acute deep venous thrombosis.
Annnals of Internal Medicine. 125:1-7. July 1, 1996.

25. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.
New England Journal of Medicine. 334:1561-7. June 13, 1996.

24. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.
New England Journal of Medicine. 334:1349-55. May 23, 1996.

23. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization.
New England Journal of Medicine. 334:1209-15. May 9, 1996.
Author willing to respond to comments

22. The clinical course of herpes zoster: a prospective study in primary care.
European Journal of General Practice. 2:12-16. March, 1996.
With authors' response

21. Atrophic gastritis and helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
New England Journal of Medicine. 334:1018-22. April 18, 1996.
With authors' response

20. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency.
New England Journal of Medicine. 334:939-45. April 11, 1996.

19. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery.
JAMA. 275:841-846. March 20, 1996.

17a. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
New England Journal of Medicine. 334:677-81. March 14, 1996.

17b. Treament of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.
New England Journal of Medicine. 334:682-7. March 14, 1996.

16. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
New England Journal of Medicine. 334:619-23. March 7, 1996.

15. A comparison of fecal occult-blood tests for colorectal-cancer screening.
New England Journal of Medicine. 334:155-9. January 18, 1996.

14. Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels.
Annals of Internal Medicine. 124:299-304. February 1, 1996.

13. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.
JAMA. 275:308-14. January 24/31, 1996.

12. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.
New England Journal of Medicine. 333:1301-7. November 16, 1995.

11. Carcinogenicity of lipid-lowering drugs.
JAMA. 275:55-60. January 3, 1996

10. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.
New England Journal of Medicine. 333:17211-5. December 28, 1995

9. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke.
Lancet. 346:1509-14. December 9, 1995.

8. A Cost Analysis of Alternative Treatments for Duodenal Ulcer.
Ann Intern Med. 123:665-72. November 1, 1995

7. Tissue plasminogen activator for acute ischemic stroke.
New England Journal of Medicine 333:1581-7. December 14, 1995.

6. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.
New England Journal of Medicine. 333:1534-39. December 7, 1995

5. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease.
New England Journal of Medicine. 333:1528-33 and 1534-39. December 7, 1995

4. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.
New England Journal of Medicine. 333:1437-43. November 30, 1995

3. Accuracy of transesophageal echocardiography for identifying left atrial thrombi.
Annals of Internal Medicine. 123:817-22. December 1, 1995
Author willing to respond to comments

2. Teratogenicity of high vitamin A intake.
New England Journal of Medicine. 333:1369-73. November 23, 1995
Author willing to respond to comments

1. HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS.
Annals of Internal Medicine. 123:641-8. November 1, 1995 

Other articles

Biomedical publishing and the Internet -- the message of the medium

Quality control on the medical Internet: proposal for a website registry

Biomedical journals and the Internet

Notes from the Harvard Conference on the Internet and Society.
May 28-31, 1996.

A strange EKG.
 

 

Copyright

Contents of Journal Club on the Web © 1995-2002 Michael Jacobson, MD, MPH. Reproduction for non-commercial purposes permitted if source is credited.

This site subscribes to the HONcode principles of the Health On the Net Foundation

---

Journal Club home page
 
 
 

Journal Club copyright Michael Jacobson, MD 1995-2003. Contents may be reproduced for non-commercial purposes, if source is credited. This website is intended as a discussion forum concerning the medical literature, not as a primary source for general medical information. Comments posted here are the responsibility of those posting them, not of this website. Inclusion here does not imply review or approval by this website.